Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Who should sponsor sleep disorders pharmaceutical trials?

× No keyword cloud information.

17 in total

1. Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors: T Bodenheimer
Journal: N Engl J Med Date: 2000-05-18 Impact factor: 91.245

Review 2. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors: Justin E Bekelman; Yan Li; Cary P Gross
Journal: JAMA Date: 2003 Jan 22-29 Impact factor: 56.272

Review 3. Industry sponsorship and authorship of clinical trials over 20 years.

Authors: Susan S Buchkowsky; Peter J Jewesson
Journal: Ann Pharmacother Date: 2004-02-24 Impact factor: 3.154

4. Relationship between drug company funding and outcomes of clinical psychiatric research.

Authors: Robert E Kelly; Lisa J Cohen; Randye J Semple; Philip Bialer; Adam Lau; Alison Bodenheimer; Elana Neustadter; Arkady Barenboim; Igor I Galynker
Journal: Psychol Med Date: 2006-08-08 Impact factor: 7.723

5. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.

Authors: Alphonso Brown; Daniel Kraft; Sara M Schmitz; Virginia Sharpless; Christopher Martin; Ritesh Shah; Nicholas J Shaheen
Journal: Clin Gastroenterol Hepatol Date: 2006-11-13 Impact factor: 11.382

6. Drug trials: stacking the deck.

Authors: Jim Giles
Journal: Nature Date: 2006-03-16 Impact factor: 49.962

Review 7. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.

Authors: Jennifer Glass; Krista L Lanctôt; Nathan Herrmann; Beth A Sproule; Usoa E Busto
Journal: BMJ Date: 2005-11-11

8. Benzodiazepine use and mortality of incident dialysis patients in the United States.

Authors: W C Winkelmayer; J Mehta; P S Wang
Journal: Kidney Int Date: 2007-09-12 Impact factor: 10.612

9. Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.

Authors: Martin B Scharf; Jed Black; Steven Hull; Rick Landin; Robert Farber
Journal: Sleep Date: 2007-06 Impact factor: 5.849

Who should sponsor sleep disorders pharmaceutical trials?

1. Uneasy alliance--clinical investigators and the pharmaceutical industry.

Review 2. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Review 3. Industry sponsorship and authorship of clinical trials over 20 years.

4. Relationship between drug company funding and outcomes of clinical psychiatric research.

5. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.

6. Drug trials: stacking the deck.

Review 7. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.

8. Benzodiazepine use and mortality of incident dialysis patients in the United States.

9. Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.

10. Medical journals are an extension of the marketing arm of pharmaceutical companies.

Review 1. Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.

2. Diagnosis and treatment of chronic insomnia.

Review 3. Advances in the management of insomnia.